|Bid||0.00 x 10000|
|Ask||0.00 x 10000|
|Day's Range||128.38 - 129.20|
|52 Week Range||82.05 - 135.14|
|Beta (3Y Monthly)||0.93|
|PE Ratio (TTM)||42.80|
|Forward Dividend & Yield||0.57 (0.45%)|
|1y Target Est||N/A|
With rapid growth projected for the market for wearable drug delivery devices, investors would be wise to consider some of the key players in the business. Two standouts are Boston-area-based Insulet (PODD) and West Pharmaceutical Services (WST), which is headquartered in Exton, Pennsylvania. Warning! GuruFocus has detected 4 Warning Signs with PODD.
Berkshire Hathaway BRK.B CEO Warren Buffett is probably as famous for analogies like these as he is for his success as an investor. For example, the "really long hill" is arguably the most powerful wealth-creation tool Buffett has, and it's something investors have at their disposal as well: time. Buffett is particularly good at sniffing out businesses with economic moats, or competitive advantages.
On a per-share basis, the Exton, Pennsylvania-based company said it had profit of 73 cents. Earnings, adjusted for restructuring costs, came to 74 cents per share. The results surpassed Wall Street expectations. ...
On a per-share basis, the Exton, Pennsylvania-based company said it had net income of 69 cents. Earnings, adjusted for pretax expenses and restructuring costs, were 73 cents per share. The results topped ...
To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
West Pharmaceutical (WST) delivered earnings and revenue surprises of 7.04% and 0.97%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Exton, Pennsylvania-based company said it had profit of 73 cents per share. Earnings, adjusted for non-recurring costs and restructuring costs, were 76 cents per share. The results beat Wall Street ...